Last updated on July 2019

Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy With BCG in Non-muscle Invasive Bladder Cancer


Find a site near you

Start Over

Research Site

Bordeaux Cedex, France
5.47miles
  Connect »